D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 95 Citations 40,435 449 World Ranking 4755 National Ranking 142

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Myocardial infarction
  • Heart failure

His primary areas of study are Internal medicine, Cardiology, Heart failure, Valsartan and Endocrinology. Internal medicine and Surgery are frequently intertwined in his study. His biological study spans a wide range of topics, including Survival rate and Placebo.

His research integrates issues of Randomized controlled trial, Randomization, ACE inhibitor and Hazard ratio in his study of Heart failure. His work carried out in the field of Valsartan brings together such families of science as Angiotensin II and Anemia. The study incorporates disciplines such as Natriuretic peptide, C-reactive protein and Confidence interval in addition to Endocrinology.

His most cited work include:

  • A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill Patients (1279 citations)
  • Effect of prone positioning on the survival of patients with acute respiratory failure (940 citations)
  • Comparison of candesartan, enalapril, and their combination in congestive heart failure : randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study : the RESOLVD Pilot Study Investigators (820 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Cardiology, Heart failure, Myocardial infarction and Endocrinology. His Ejection fraction, Valsartan, Natriuretic peptide and Atrial fibrillation study in the realm of Internal medicine connects with subjects such as In patient. His work deals with themes such as Clinical trial, Surgery and Blood pressure, Diastole, which intersect with Cardiology.

His Heart failure research includes elements of Proportional hazards model, Heart disease, Intensive care medicine and Hazard ratio. His Myocardial infarction research incorporates themes from Hemodynamics, Lisinopril and ACE inhibitor. Angiotensin II and Diabetes mellitus are among the areas of Endocrinology where the researcher is concentrating his efforts.

He most often published in these fields:

  • Internal medicine (72.94%)
  • Cardiology (53.14%)
  • Heart failure (38.45%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (72.94%)
  • Cardiology (53.14%)
  • Heart failure (38.45%)

In recent papers he was focusing on the following fields of study:

Roberto Latini focuses on Internal medicine, Cardiology, Heart failure, Ejection fraction and Sepsis. His Internal medicine research includes themes of Gastroenterology and Diabetes mellitus. His studies deal with areas such as Body mass index and Type 2 diabetes as well as Cardiology.

Roberto Latini combines subjects such as Obesity paradox, Incidence and Bioinformatics with his study of Heart failure. His research in Ejection fraction intersects with topics in Pulmonary embolism, Ambulatory, Cause of death and Hazard ratio. He has researched Sepsis in several fields, including Oxygen transport and Albumin.

Between 2018 and 2021, his most popular works were:

  • Understanding Lactatemia in Human Sepsis. Potential Impact for Early Management. (40 citations)
  • Pentraxin 3 in Cardiovascular Disease. (26 citations)
  • Predicting the effects of supplemental EPA and DHA on the omega-3 index. (22 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Myocardial infarction
  • Surgery

His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, Natriuretic peptide and Gastroenterology. His Internal medicine study incorporates themes from Diabetes mellitus and Endocrinology. The various areas that Roberto Latini examines in his Cardiology study include Resuscitation and Cardiopulmonary resuscitation.

His study in Heart failure is interdisciplinary in nature, drawing from both Body mass index, Inflammation and Clinical endpoint. In his research, N terminal pro b type natriuretic peptide is intimately related to Troponin T, which falls under the overarching field of Natriuretic peptide. As a member of one scientific family, Roberto Latini mostly works in the field of Ejection fraction, focusing on Interquartile range and, on occasion, Atrial fibrillation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill Patients

L Gattinoni;L Brazzi;P Pelosi;R Latini.
The New England Journal of Medicine (1995)

1884 Citations

Effect of prone positioning on the survival of patients with acute respiratory failure

Luciano G. Gattinoni;Gianni Tognoni;Antonio Pesenti;Paolo Taccone.
The New England Journal of Medicine (2001)

1473 Citations

Comparison of candesartan, enalapril, and their combination in congestive heart failure : randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study : the RESOLVD Pilot Study Investigators

R. S. McKelvie;S. Yusuf;D. Pericak;A. Avezum.
Circulation (1999)

1303 Citations

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Inder S. Anand;Lloyd D. Fisher;Yann Tong Chiang;Roberto Latini.
Circulation (2003)

1085 Citations

Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

Roberto Latini;Roberto Latini;Serge Masson;Inder S. Anand;Emil Missov.
Circulation (2007)

926 Citations

Albumin Replacement in Patients with Severe Sepsis or Septic Shock

Pietro Caironi;Gianni Tognoni;Serge Masson;Roberto Fumagalli.
The New England Journal of Medicine (2014)

916 Citations

Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic overview of individual data from 100,000 patients in randomized trials

M G Franzosi;E Santoro;G Zuanetti;C Baigent.
Circulation (1998)

814 Citations

Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor

Michael Brines;Giovanni Grasso;Giovanni Grasso;Fabio Fiordaliso;Alessandra Sfacteria.
Proceedings of the National Academy of Sciences of the United States of America (2004)

785 Citations

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

Laura Calvillo;Roberto Latini;Jan Kajstura;Annarosa Leri.
Proceedings of the National Academy of Sciences of the United States of America (2003)

774 Citations

Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis.

Sachin Sud;Jan O. Friedrich;Jan O. Friedrich;Paolo Taccone;Federico Polli.
Intensive Care Medicine (2010)

588 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Roberto Latini

John J.V. McMurray

John J.V. McMurray

University of Glasgow

Publications: 174

Alberto Mantovani

Alberto Mantovani

Humanitas University

Publications: 145

John G.F. Cleland

John G.F. Cleland

National Institutes of Health

Publications: 117

James L. Januzzi

James L. Januzzi

Harvard University

Publications: 104

Aldo P. Maggioni

Aldo P. Maggioni

Heart Care Foundation, ANMCO Research Center, Florence

Publications: 100

Dirk J. van Veldhuisen

Dirk J. van Veldhuisen

University Medical Center Groningen

Publications: 97

Faiez Zannad

Faiez Zannad

University of Lorraine

Publications: 95

Karl Swedberg

Karl Swedberg

University of Gothenburg

Publications: 85

Marco Metra

Marco Metra

University of Brescia

Publications: 84

Adriaan A. Voors

Adriaan A. Voors

University Medical Center Groningen

Publications: 83

Scott D. Solomon

Scott D. Solomon

Brigham and Women's Hospital

Publications: 81

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 79

Alan S. Maisel

Alan S. Maisel

University of California, San Diego

Publications: 79

Torbjørn Omland

Torbjørn Omland

Akershus University Hospital

Publications: 78

Gerasimos Filippatos

Gerasimos Filippatos

National and Kapodistrian University of Athens

Publications: 75

Marc A. Pfeffer

Marc A. Pfeffer

Brigham and Women's Hospital

Publications: 72

Trending Scientists

Alberto Marchetti-Spaccamela

Alberto Marchetti-Spaccamela

Sapienza University of Rome

Qiang Zhang

Qiang Zhang

Dalian University of Technology

Peter Gerjets

Peter Gerjets

University of Tübingen

Olaf Dössel

Olaf Dössel

Karlsruhe Institute of Technology

Lori L. Bonnycastle

Lori L. Bonnycastle

National Institutes of Health

Rafael Rubio de Casas

Rafael Rubio de Casas

University of Granada

Jordi Voltas

Jordi Voltas

University of Lleida

Andrew J. Putnam

Andrew J. Putnam

University of Michigan–Ann Arbor

Davide Ruggero

Davide Ruggero

University of California, San Francisco

Brian Schaffhausen

Brian Schaffhausen

Tufts University

Michael W. Rich

Michael W. Rich

Washington University in St. Louis

Loïc Guillevin

Loïc Guillevin

Université Paris Cité

Eiliv Lund

Eiliv Lund

University of Tromsø - The Arctic University of Norway

M. Isabel Fernandez

M. Isabel Fernandez

College of Osteopathic Medicine of the Pacific

Jason M. Fletcher

Jason M. Fletcher

University of Wisconsin–Madison

Fabio Governato

Fabio Governato

University of Washington

Something went wrong. Please try again later.